Principal Investigator
Alan Pollack
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20090284
Clinical Trial Summary
SCCC 2009013 PREDICTIVE VALUE OF MOLECULAR MARKERS FOR PROSTATE CANCER OUTCOME AFTER RADIOTHERAPY
Phase
Funding Agency/Sponsor
Institutional
Disease
Prostate, Bladder, and Kidney Cancers
Contact Information
Phone Number
+1 (305) 2434916